RESEARCH As Vyant Bio continues its wind-down, the neuroscience research assets of its subsidiary StemoniX have officially been picked up by […]
On Tuesday, October 24, 2023, AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX
Latest Acquisition Lands AxoSim in the News Read more
Check out AxoSim CEO Lowry Curley PhD, and Obatala Sciences CEO Trivia Frazier’s, PhD, MBA, op-ed highlighting their experiences growing companies in Southeast Louisiana and how
Nola.Com Op-Ed Featuring AxoSim CEO Lowry Curley, PhD Read more
Our CEO Lowry Curley, PhD, had the honor of being quoted in Genetic Engineering and Biotechnology New’s July cover story.
AxoSim CEO Quoted in Cover Story for GEN: Genetic Engineering and Biotechnology News Read more
May 11, 2020 Recent publication in ALTEX demonstrates prediction of clinical peripheral neuropathy by chemotherapeutic drugs using NerveSim™ powered by
Publication Confirms NerveSim’s Ability to Recapitulate Peripheral Neuropathy Read more
AxoSim Chief Science Officer and Co-Founder, Dr. Michael J. Moore, presented Nerve-on-a-Chip pain model at the NIH Tissue Chips Consortium
AxoSim Co-Founder, Dr. Michael J. Moore, Presents at NIH Tissue Chips Consortium Read more
We are excited to announce that our paper, “Engineering a 3D functional human peripheral nerve in vitro using the Nerve-on-a-Chip®
AxoSim’s Article in Top 100 Neuroscience Paper Downloads of 2019 Read more
The cover story of the August 2018 Issue of Biz New Orleans featured AxoSim’s CEO and Co-Founder Dr. Lowry Curley.
AxoSim CEO featured as cover story in Biz New Orleans Read more
AxoSim, Inc., the premier provider of neuroscience discovery platforms that mimic the structure and function of the human nervous system,
AxoSim licenses Mini-Brain technology from Johns Hopkins Read more
